NCT03619252 2022-08-31
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 4 Completed
Clinical Trials
10 trialsNCT00013871 2021-11-01
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
National Institute of Allergy and Infectious Diseases (NIAID)
Phase NA Completed
NCT01239875 2020-01-14
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01852591 2017-02-02
PCV13
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00741039 2015-11-20
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00445484 2015-08-24
Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00919321 2014-02-19
KLL2
Tampere University Hospital
Phase 4 Completed
NCT00499577 2014-01-10
Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00323557 2012-12-05
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00829595 2009-01-27
Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease
Cedars-Sinai Medical Center
Phase NA Completed